EMA Authorised: Levodopa/Carbidopa/Entacapone Orion (levodopa;carbidopa;entacapone) — Orion Corporation

View source ↗

Summary

The European Medicines Agency authorised Levodopa/Carbidopa/Entacapone Orion for the treatment of Parkinson's disease, manufactured by Orion Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Levodopa/Carbidopa/Entacapone Orion (levodopa; carbidopa; entacapone)

Snippet

Status: Authorised. Therapeutic area: Parkinson Disease. MAH: Orion Corporation. Decision date: 21/01/2025